Beximco Pharmaceuticals (LON:BXP) Shares Up 1.4% – Here’s Why

Shares of Beximco Pharmaceuticals Limited (LON:BXP) traded up 1.4% during mid-day trading on Thursday . The company traded as high as GBX 36.70 ($0.47) and last traded at GBX 36 ($0.46). 37,663 shares changed hands during mid-day trading, a decline of 76% from the average session volume of 157,696 shares. The stock had previously closed at GBX 35.50 ($0.45).

Beximco Pharmaceuticals Stock Performance

The firm has a fifty day moving average of GBX 30.53 and a 200 day moving average of GBX 33.20. The firm has a market capitalization of £160.60 million, a PE ratio of 450.00 and a beta of 0.61. The company has a debt-to-equity ratio of 14.73, a quick ratio of 0.37 and a current ratio of 1.80.

Beximco Pharmaceuticals Company Profile

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.